Treatment of Seasonal Allergic Rhinitis with Budesonide and Disodium Cromoglycate
- 1 January 1985
- Vol. 40 (1) , 65-69
- https://doi.org/10.1111/j.1398-9995.1985.tb04156.x
Abstract
The efficacy and side effects of budesonide and disodium cromoglycate (DSCG) in seasonal allergic rhinitis were compared. In a double-blind, double-dummy comparative study, 43 patients with seasonal allergic rhinitis were either treated with budesonide (200 .mu.g twice daily) or DSCG (5.2 mg 5 times daily). After a 1 wk run-in period sneezing bouts and total nasal symptoms were significantly different between the treatment groups during the whole treatment period. The scorings for nasal blockage were significantly different during the last 2 wk of treatment. All differences were in favor of budesonide treatment. The patients'' assessment of the treatment favored budesonide (P < 0.02). Side effects were few and mild, but 1 patient from the budesonide group stopped treatment because of headache.Keywords
This publication has 9 references indexed in Scilit:
- Budesonide — A New Steroid for Intranasal UseAllergy, 1981
- Treatment of Grass Pollen-Induced Hay Fever with Intranasal Budesonide.Allergy, 1981
- Reduction of Metacholine‐Induced Nasal Secretion by Treatment with a New Topical Steroid in Perennial Non‐Allergic RhinitisAllergy, 1981
- A comparative trial of intra‐nasal beclomethasone dipropionate and sodium cromoglycate in patients with chronic perennial rhinitisClinical and Experimental Allergy, 1980
- A comparison of intranasal betamethasone valerate and sodium cromoglycate in seasonal allergic rhinitisClinical and Experimental Allergy, 1975
- Intra-nasal beclomethasone dipropionate and intra-nasal sodium cromoglycate: a comparative trialClinical and Experimental Allergy, 1974
- DISODIUM CROMOGLYCATE (LOMUDAL®) IN THE TREATMENT OF HAY FEVERAllergy, 1973
- Treatment of seasonal allergic rhinitis with 2% sodium cromoglycate (BP) solutionClinical and Experimental Allergy, 1973